News
February 15, 2020
Kodikaz Awarded Research Seed Grant from Biolocity
Kodikaz was awarded a Seed grant from Biolocity. The competitive grant process was awarded to help the company further the product development of its targeted cell specific Zip-Code technology for clinical applications in Multiple Myeloma. The grant is for 6 months of MORE
November 2, 2019
Kodikaz Therapeutic Inaugural Winner of Boehringer Ingelheim NYC Innovation Prize
Kodikaz Therapeutic Solutions, Inc. won the first ever Boehringer Ingelheim NYC Innovation Prize. On August 15 2019, Kodikaz competed with many other early stage biotechs from across NYC and finished first in the competition. The prize was the Golden Ticket which comes MORE